RUSNANOPRIZE Finalists
Finalists of the RUSNANOPRIZE 2016 International Nanotechnology Award have been named
The International RUSNANOPRIZE 2016 Award Committee, which is awarded for the best nanotechnology developments introduced into mass production, has identified three finalists. The names of the award winners will be announced at the Open Innovations Forum on October 26. The RUSNANOPRIZE Prize was established in 2009 and is awarded annually in one of four scientific areas: "Nanomaterials and surface modification", "Medicine, Pharmacology and Biotechnology", "Optics and Electronics", "Energy Efficiency and Green Technologies". The award can be given to a group of scientists (no more than three people) and the company that commercialized their development. The decision on the laureates is made by an International Committee, which includes scientists and business representatives who have achieved outstanding results in the field in which the prize is awarded this year. In 2016, the prize will be awarded for works in the field of medicine, pharmacology and biotechnology. The shortlist based on the results of the committee's voting included:
- Chad Mirkin, Professor at Northwestern University (Illinois, USA), and Nanosphere, Inc. Mirkin has developed a new type of biological markers constructed from tightly packed and strictly oriented nucleic acid molecules located on the surface of spherical nanoparticles. As part of such nanoobjects, nucleic acids acquire new physicochemical and biological properties. Based on these markers, the company Nanosphere systems for clinical molecular diagnostics, regulation of gene expression and management of the immune system.
- Alexander Kabanov, Professor at the University of North Carolina (USA) and Lomonosov Moscow State University; Kazunori Kataoka, Professor and CEO of the Nanomedicine Innovation Center (iCONM) in Japan; Min-Hyo Seo, Vice President, Director of the R&D Center of Samyang Biopharmaceuticals Corp. (South Korea), as well as Samyang Biopharmaceuticals itself. This international group of scientists has developed an antitumor drug Genexol-PM. Nanotechnology in it provides targeted delivery of the active substance to the target cells. Today, Samyang Biopharmaceuticals produces Genexol-PM in Russia, as well as in many Asian countries – in South Korea, the Philippines, Vietnam, Indonesia and India.
- Tatiana Tennikova, Professor at St. Petersburg State University, Frantisek Svec, Professor at the Lawrence Berkeley National Laboratory (USA) and Beijing University of Chemical Technology (China), as well as BIA Separations, D.O.O.. This group has developed a new polymer material for the so-called "monolithic" columns required for high-performance liquid chromatography. Such monolithic columns are widely used in chromatography of large biomolecules. The emergence of this technology has revolutionized chromatography, with its help, enzymes, microbial toxins, pharmaceuticals, nucleic acids are isolated. Since the 1990s, this material has been produced by BIA Separations, which is the developer of the first commercial chromatographic column with a polymer monolithic carrier and a supplier of large manufacturers of chromatographic equipment. According to experts, the market for monolithic speakers and carriers for bioseparation is now more than $ 1 billion.
Portal "Eternal youth" http://vechnayamolodost.ru
21.10.2016